Herlev Hospital
Herlev, Denmark, 2880
NCT Number: NCT01267760
The purpose of this study is to investigate whether recycled dialysis fluid can supply enough clearance for hemodiaysis patients.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 2
Herlev, Denmark, 2880
Conventional hemodialysis uses large amounts of water, which hinders travel possibilies for home hemodialysis (HD) patients. We have developed a recycling system using 25-30 l dialysate per dialysis. In vitro investigations show that this results in adequate dialysis.
12 HD patients will be studied during two dialysis sessions. The first HD will be a conventional 4 hour dialysis, using single pass dialysate. The second will be an 8-hour HD using multipass (recycled) dialysate 25-30 l. Clearance of urea, creatinine, phosphate and cobalamin will be measured both in the patient and the dialysate. Patient symptoms will be recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8-hour dialysis using a recycled dialysis bath of 25-30 l
Other names: dialysis, hemodialysis, dialysate
Time frame: 9 hours
Time frame: 9 hours
Time frame: 9 hours
Herlev Hospital
Other
Acronym: MHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05076318
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Aarhus N, Denmark
View Trial DetailsNCT06875115
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dalin, Chiayi, Taiwan
View Trial DetailsNCT04768309
CKD, Female Urogenital Diseases
Pierre-Bénite, Rhône, France
View Trial DetailsNCT07086430
End Stage Renal Disease on Dialysis, Female Urogenital Diseases
View Trial Details